FeesSafety
Pluang+

Eupraxia Pharmaceuticals to present at multiple conferences and host virtual Analyst Day on Nov 13, 2026

Market News
22 Oct 2026
GlobeNewsWire
View Source
Neutral
Eupraxia Pharmaceuticals to present at multiple conferences and host virtual Analyst Day on Nov 13, 2026

Eupraxia Pharmaceuticals announced its participation in several upcoming healthcare conferences, including virtual and in-person events in October and November 2026. The company will also host a virtual Analyst Day on November 13, 2026, focusing on its EP-104GI treatment for Eosinophilic Esophagitis. Eupraxia is developing its proprietary Diffusphere™ technology for targeted, extended-release drug delivery, aiming to improve safety and efficacy in treating diseases with high unmet needs. These events provide opportunities for Eupraxia to showcase its clinical progress and engage with investors and the medical community.

Eupraxia Pharmaceuticals' upcoming conferences and virtual Analyst Day provide context for healthcare sector activity. For readers following healthcare stocks, here is Pluang's market snapshot as of Oct 22, 2026 19:13 WIB: out of 150 priced US health-sector stocks, 63 rose and 79 fell today. Notable movers include IONS at USD 45.36 with a 1-day change of +2.46%, MRVI at USD 7.40 down 2.25%, and ABCL at USD 11.98 with a Pluang order activity of 21% Sell / 79% Buy and a typical hold time of 41 days.

More News

Dune launches real-time onchain market data feeds covering 200+ venues and tokenized U.S. stocks trading.

Dune launches real-time onchain market data feeds covering 200+ venues and tokenized U.S. stocks trading.

Dune Analytics has launched Dune Market Data Feeds, providing real-time trade data from over 200 onchain trading venues across 12 blockchains, including tokenized U.S. stocks from XLayer. This service enables institutional investors to track onchain ...

Market News
Bullish
44 minutes ago
Lockheed Martin beats Q3 2026 earnings estimates with record backlog of $292B

Lockheed Martin beats Q3 2026 earnings estimates with record backlog of $292B

Lockheed Martin reported strong Q3 2026 results, beating Wall Street estimates with earnings of $7.97 per share and sales of $20.7 billion, up 11% year-over-year. Net earnings rose 14% to $1.8 billion, supported by a record backlog of $292 billion, i...

Company Fundamentals
Bullish
1 hour ago
IBM's Q3 beats expectations, software growth drives price target hike to $280

IBM's Q3 beats expectations, software growth drives price target hike to $280

IBM reported strong Q3 results with revenue of $17.1 billion and adjusted earnings of $2.95 per share, surpassing analyst estimates. Software revenue grew 9%, led by Red Hat and OpenShift, while AI-related consulting work also contributed significant...

Company Fundamentals
Bullish
2 hours ago
CenterPoint Energy gets 'Buy' rating ahead of Q3 earnings with expected $2.16B revenue and $0.50 EPS.

CenterPoint Energy gets 'Buy' rating ahead of Q3 earnings with expected $2.16B revenue and $0.50 EPS.

Cowen & Co. initiated a 'Buy' rating on CenterPoint Energy before its Q3 earnings report due October 27, 2026. Analysts expect $2.16 billion in revenue, an 8.4% increase year-over-year, and earnings of $0.50 per share, steady from last year. The comp...

Analyst Insights
Bullish
2 hours ago
Drofa Comms launches Women Leading the Way 2026 to promote equal recognition for women experts in finance.

Drofa Comms launches Women Leading the Way 2026 to promote equal recognition for women experts in finance.

Drofa Comms has released the Women Leading the Way Digital Magazine 2026, aiming to highlight women experts in finance on equal terms with men. The digital magazine features insights from 25 industry professionals and covers topics like AI in wealth ...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App